REORDERNCT07843056
A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With Schizophrenia.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Score PANSS
Timeframe: From enrollment to the end of treatment at 12 weeks
Arms and interventions
WAS123Experimental
oral dose
AripiprazoleActive comparator
oral daily dose
Drugs: WAS123, Aripiprazole (Fixed dose)
Sites
1 site in 1 country
- Clinica ViverSão Paulo, São Paulo, Brazil